USFDA approves Strides Pharma Global stomach ulcer treatment drug Ruchika Sharma22 May 2024 11:30 AM ISTSucralfate is used to treat stomach ulcers, gastroesophageal reflux disease, radiation proctitis, and stomach inflammation and to prevent stress...
Strides Pharma Science arm gets USFDA nod for Hypocalcemia drug Sevelamer Carbonate Ruchika Sharma10 May 2024 4:23 PM ISTSevelamer Carbonate is a phosphate binder, that helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated phosphorus.
Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine Ruchika Sharma9 April 2024 12:30 PM ISTThe product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.
Strides Pharma Science arm secures USFDA nod for Gabapentin tablets for neuropathic pain treatment Ruchika Sharma5 March 2024 4:11 PM ISTGabapentin is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain.
Strides Pharma shares sold by 2 entities for Rs 81 crore Ruchika Sharma10 Feb 2024 1:30 PM ISTBangalore: Two entities including Bajaj Finance have sold shares of Strides Pharma Science for Rs 81 crore through open market transactions. According...
Strides Pharma Science Singapore arm gets USFDA okay for fibromyalgia drug Pregabalin Ruchika Sharma27 Jan 2024 12:30 PM ISTBangalore: Strides Pharma Science Limited has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has...
Strides gets USFDA nod for Generic Suprep Bowel Prep Kit Ruchika Sharma23 Nov 2023 11:30 AM ISTThe company has set a target to launch ~ 60 new products over three years in the US.
Strides Pharma Science Singapore arm gets USFDA nod for Levetiracetam Oral Solution Ruchika Sharma21 Nov 2023 11:30 AM ISTIt is used in the treatment of seizures.
Strides Pharma Science posts consolidated net loss of Rs 149 crore in Q2 Ruchika Sharma30 Oct 2023 10:00 AM ISTNew Delhi: Strides Pharma Science has reported a consolidated net loss of Rs 149 crore for the second quarter ended September 30, 2023.The drug firm...
Strides to sell manufacturing facility in Singapore for Rs 125 crore Ruchika Sharma29 Oct 2023 4:00 PM IST"Proceeds from the transaction will be utilized for debt reduction," Strides stated.
Strides Pharma bags USFDA nod for Efavirenz, Emtricitabine, Tenofovir Disproxil Fumurate tablets for HIV Ruchika Sharma5 Oct 2023 11:36 AM ISTBangalore: Strides Pharma Science Limited has announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has...
Strides Pharma to spin off CDMO, soft gelatin business into new entity Ruchika Sharma26 Sept 2023 11:48 AM ISTBengaluru: India's Strides Pharma Science has said it would spin off its contract development and manufacturing organisation (CDMO)...
